Oruka Therapeutics, Inc. ORKA Investments and Cash
Investments and Cash at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentsAndCash.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s investments and cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s investments and cash?
- Oruka Therapeutics, Inc. (ORKA) reported investments and cash of $496M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s investments and cash changed year-over-year?
- Oruka Therapeutics, Inc.'s investments and cash increased by 33.0% year-over-year, from $373M to $496M.
- What does investments and cash mean?
- This represents the total value of cash, cash equivalents, and investment securities held by the company that are classified as non-current assets. It reflects the company's long-term liquidity position and its ability to fund multi-year research and development initiatives without immediate reliance on external financing.